Login

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q3 FY2020
As of Sep 30, 2020
Q2 FY2020
As of Jun 30, 2020
Q1 FY2020
As of Mar 31, 2020
Q4 FY2019
As of Dec 31, 2019
Q3 FY2019
As of Sep 30, 2019
Q2 FY2019
As of Jun 30, 2019
Q1 FY2019
As of Mar 31, 2019
Q4 FY2018
As of Dec 31, 2018
Q3 FY2018
As of Sep 30, 2018
Q2 FY2018
As of Jun 30, 2018
Q1 FY2018
As of Mar 31, 2018
Q4 FY2017
As of Dec 31, 2017
Q3 FY2017
As of Sep 30, 2017
Q2 FY2017
As of Jun 30, 2017
Q1 FY2017
As of Mar 31, 2017
Q4 FY2016
As of Dec 31, 2016
Q3 FY2016
As of Sep 30, 2016
Q2 FY2016
As of Jun 30, 2016
Q1 FY2016
As of Mar 31, 2016
Q4 FY2015
As of Dec 31, 2015
ASSETS
Current assets:
Cash and cash equivalents
Restricted cash
Receivables:
Receivables:
Billed
Unbilled
Net receivables
Employee advances and miscellaneous receivables, net
Total receivables
Prepaid expenses and other current assets
Total current assets
Computer and other equipment
Furniture and fixtures
Leasehold improvements
Software
Property, equipment and software
Less accumulated depreciation and amortization
Property, equipment and software, net
Operating lease right-of-use assets (Note 9)
Goodwill
Intangible assets, less accumulated amortization of $49,369 in 2020 and $47,097 in 2019
Unbilled receivables
Deferred income taxes
Other assets
Total assets
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Accounts payable and accrued expenses
Accrued payroll and related expenses
Current portion of operating lease liabilities (Note 9)
Refund liabilities
Deferred revenue
Current portion of debt (Note 5)
Compensation Liability, Long-term Incentive, Current
Current portion of long-term incentive compensation liability
Business acquisition obligations (Note 1)
Total current liabilities
Noncurrent business acquisition obligations (Notes 1 and 12)
Long-term debt (Note 5)
Long-term operating lease liabilities (Note 9)
Refund liabilities
Deferred income taxes (Note 8)
Other long-term liabilities
Total liabilities
Shareholders’ equity (Note 2):
Common stock, no par value; $.01 stated value per share. Authorized 50,000,000 shares; 23,561,493 shares issued and outstanding at September 30, 2020 and 23,369,433 shares issued and outstanding at December 31, 2019
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Total shareholders’ equity
Total liabilities and shareholders' equity
Common Stock, No Par Value

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support